Challenges in treating obsessive-compulsive disorder: Introduction

Journal of Clinical Psychology

Volumn 60, Issue 11, 2004, Pages 1127-1132

  Wilhelm, Sabine ^a   Tolin, David F ^b   Steketee, Gail ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Cognitive behavioral therapy; Compulsions; Exposure; Obsessions; Obsessive compulsive disorder; Pharmacotherapy; Response prevention

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; BEHAVIOR THERAPY; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COMPULSION; COMPULSIVE HOARDING; DEPRESSION; DRUG USE; EXPOSURE AND RESPONSE PREVENTION THERAPY; HUMAN; INCOMPLETENESS; NEUROSURGERY; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; PATIENT EDUCATION; PSYCHOTHERAPY; REPUGNANT OBSESSION; REVIEW; SYMPTOM; TREATMENT INDICATION;

ADULT; CHILD; COGNITIVE THERAPY; DESENSITIZATION, PSYCHOLOGIC; HUMANS; INHIBITION (PSYCHOLOGY); OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 6344274707     PISSN: 00219762     EISSN: None     Source Type: Journal    
DOI: 10.1002/jclp.20077     Document Type: Review

References (16)

1. Abramowitz, J., Franklin, M.E., & Foa, E.B. (2002). Empirical status of cognitive behavioral therapy for obsessive compulsive disorder. Romanian Journal of Cognitive Behavioral Therapy, 2, 89-104.
2. Bland, R.C., Orn, H., & Newman, S.C. (1988). Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatrica Scandinavica, 77(Suppl. 338), 24-32.
3. Cottraux, J., Note, I., Yao, S.N., Lafont, S., Note, B., Mollard, E., Bourvard, M., Sauteraud, A., Bourgeois, M., & Dartigues, J.F. (2001). A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive-compulsive disorder. Psychotherapy and Psychosomatics, 70, 288-297.
4. Emmelkamp, P.M.G., & Foa, E.B. (1983). Failures are a change. In E.B. Foa & P.M.G. Emmelkamp (Eds.), Failures in behavior therapy (pp. 1-9). New York: Wiley.
5. Greist, J.H., Jefferson, J.W., Kobak, K.A., Katzelnick, D.J., & Serlin, R.C. (1995). Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta-analysis. Archives of General Psychiatry, 52(1), 53-60.
6. Jenike, M.A. (2004). Obsessive-compulsive disorder. New England Journal of Medicine, 350, 259-265.
7. Kozak, M.J., Liebowitz, M., & Foa, E.B. (2000). Cognitive behavior therapy and pharmacotherapy for obsessive-compulsive disorder: The NIMH-sponsored collaborative study. In W.K. Goodman, M.V. Rudorfer, & J.D. Maser (Eds.), Obsessive-compulsive disorder: Contemporary issues in treatment (pp. 501-530). Hillsdale, NJ: Lawrence Erlbaum.
8. March, J.S., Frances, A., Carpenter, D., & Kahn, D.A. (1997). The expert consensus guideline series: Treatment of obsessive-compulsive disorder. Journal of Clinical Psychiatry, 58 (Suppl. 4), 1-72.
9. Pato, M.T., Zohar-Kadouch, R., Zohar, J., & Murphy, D.L. (1988). Return of symptoms after discontinuation of clomipramine in patients with obsessive compulsive disorder. American Journal of Psychiatry, 145, 1521-1525.
10. Rachman, S., & Hodgson, R.J. (1980). Obsessions and compulsions. Englewood Cliffs, NJ: Prentice-Hall.
11. Rasmussen, S.A., & Eisen, J.L. (1990). Epidemiology and clinical features of obsessive-compulsive disorder. In M.A. Jenike, L. Baer, & W.E. Minichiello (Eds.), Obsessive-compulsive disorders: Theory and management (2nd ed., pp. 10-29). Chicago: Year Book Medical.
12. Riggs, D.S., & Foa, E.B. (1993). Obsessive compulsive disorder. In D.H. Barlow (Ed.), Clinical handbook of psychological disorders: A step-by-step treatment manual (2nd ed., pp. 189-239). New York: Guilford.
13. Robins, L.N., Helzer, J.E., Weissman, M.M., Orvaschel, H., Gruenberg, E., Burke, J.D., & Regier, D.A. (1984). Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry, 41, 958-967.
14. Stanley, M.A., & Turner, S.M. (1995). Current status of pharmacological and behavioral treatment of obsessive-compulsive disorder. Behavior Therapy, 26, 163-186.
15. Steketee, G. (1997). Disability and family burden in obsessive compulsive disorder. Canadian Journal of Psychiatry, 42, 919-928.
16. Wilhelm, S., Steketee, G., Fama, J., & Golan, E. (2003, November). A controlled trial investigating cognitive therapy for OCD: Treatment outcome, acceptability, and mechanisms of improvement. In S. Wilhelm (Chair), Mechanisms and predictors of effective OCD treatment. Symposium conducted at the meeting of the Association for Advancement of Behaviour Therapy, Boston.